Inhibition of AT(1) receptor internalization by concanavalin A blocks angiotensin II-induced ERK activation in vascular smooth muscle cells - Involvement of epidermal growth factor receptor proteolysis but not AT(1) receptorinternalization

Citation
H. Tang et al., Inhibition of AT(1) receptor internalization by concanavalin A blocks angiotensin II-induced ERK activation in vascular smooth muscle cells - Involvement of epidermal growth factor receptor proteolysis but not AT(1) receptorinternalization, J BIOL CHEM, 275(18), 2000, pp. 13420-13426
Citations number
50
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
275
Issue
18
Year of publication
2000
Pages
13420 - 13426
Database
ISI
SICI code
0021-9258(20000505)275:18<13420:IOARIB>2.0.ZU;2-G
Abstract
Recent studies of beta(2)-adrenergic receptor suggest that agonist-promoted receptor internalization may play an important role in extracellular signa l-regulated kinase (ERK) activation by G protein-coupled receptors, In the present study, we explored the effects of angiotensin II (Ang II) type-1 re ceptor (AT(1)) internalization on Ang II-induced activation of ERK using th e receptor internalization blocker concanavalin A (ConA) and the carboxyl t erminus-truncated receptor mutants with impaired internalization. ConA inhi bited AT(1) receptor internalization without affecting ligand binding to th e receptor, Ang II-induced generation of second messengers, and activation of tyrosine kinases Src and Pyk2 in vascular smooth muscle cells (VSMC), Co nA blocked ERK activation evoked by Ang II and the calcium ionophore A23187 , Impairment of AT(1) receptor internalization by truncating the receptor c arboxyl terminus did not affect Ang II-induced ERK activation. ConA induced proteolytic cleavage of the epidermal growth factor (EGF) receptor at carb oxyl terminus and abolished Ang II-induced transactivation of the EGF recep tor, which is critical for ERR activation by Ang II in VSMC, ConA also indu ced proteolysis of erbB-2 but not platelet-derived growth factor receptor. Thus, ConA blocks Ang II-induced ERR activation in VSMC through a distinct mechanism, the ConA-mediated proteolysis of the EGF receptor.